LifeVantage Corporation engages in the identification, research, development, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, and skin and hair care products. The company offers Protandim, a line of scientifically-validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes. It also provides anti-aging skin care products, including facial cleansers, perfecting lotions, eye serums, anti-aging creams, and hand creams, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name. The company sells its products through its website, as well as through a network of independent distributors in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand, and China. LifeVantage Corporation is headquartered in Sandy, Utah.
IPO Year:
Exchange: NASDAQ
Website: lifevantage.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/14/2025 | $35.00 | Buy | Craig Hallum |
| 12/19/2024 | $26.00 | Buy | Lake Street |
SALT LAKE CITY, Jan. 16, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, is proud to announce the addition of Todd Thompson as Chief Information and Innovation Officer. Todd brings decades of experience driving transformative technology solutions and business growth for prominent global organizations. "We are thrilled to welcome Todd to the LifeVantage team," said Steve Fife, President and CEO of LifeVantage. "Todd's exceptional track record in technology leadership and his forward-thinking approach will be pivotal as we continue along our growth path
SALT LAKE CITY, Jan. 13, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, hosted its annual Global Kickoff on Saturday, January 11, 2025. Thousands of the company's independent Consultants around the world joined the live broadcast to celebrate the company's bold vision for 2025, which emphasized momentum, continued innovation, and international expansion of the MindBody GLP-1 System™. The company also announced that the Philippines, Taiwan, Hong Kong, and Singapore markets will transition to the Evolve Compensation Plan on March 1, with Thailand, the fina
SALT LAKE CITY, Jan. 13, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leader in cellular activation of optimal health processes, today announced the results of a groundbreaking third-party cell study on the synergistic impact of Protandim® Nrf2 Synergizer® and the MindBody GLP-1 System™. The findings reveal that when used together in a combination known as the Healthy Weight Stack, the products not only amplify each other's benefits, but also activate 22 new genes that target key causes of age-related organ decline to help organs stay structurally strong, support tissue cells' regeneration and repair, and improve coordination, signaling and impulses with tissue cells a
SALT LAKE CITY, Jan. 08, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced preliminary revenue results for the second quarter ended December 31, 2024, and raised its fiscal 2025 revenue guidance. Preliminary Second Quarter Fiscal 2025 Highlights: Revenue of approximately $67.5 million, an increase of 31% from the prior year period, and up 43% sequentially from the first fiscal quarterActive Account growth in the Americas of 22.7% in comparison to the prior year period, and up 25.4% sequentially from the first fiscal quarterActive Account
SALT LAKE CITY, Jan. 06, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer, and Carl Aure, Chief Financial Officer, will participate in the 27th Annual ICR Conference to be held January 13-15, 2025 in Orlando, FL. Mr. Fife and Mr. Aure will present at approximately 10:30 a.m. Eastern Time on Monday, January 13, 2025. A webcast of their presentation will be accessible on the News & Events section of the Company's Investor Relations website at https://lifevantage.gcs-web.com/ or directly
SALT LAKE CITY, Dec. 03, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer, and Carl Aure, Chief Financial Officer, will participate in the Water Tower Fireside Chat Series on Tuesday, December 3, 2024. Mr. Fife and Mr. Aure will present at approximately 11:00 a.m. Eastern Time on Tuesday, December 3, 2024. A webcast of their presentation will be accessible on the News & Events section of the Company's Investor Relations website at https://lifevantage.gcs-web.com/ or directly here. Abo
SALT LAKE CITY, Nov. 07, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that Steve Fife, President and Chief Executive Officer and Carl Aure, Chief Financial Officer will participate in the Sidoti Micro Cap Conference, to be held November 13-14, 2024. Mr. Fife and Mr. Aure will meet virtually with investors and present at approximately 1:00 p.m. Eastern Time on Wednesday, November 13, 2024. A live webcast of their presentation will be accessible on the News & Events section of the Company's Investor Relations website at https://lifevanta
SALT LAKE CITY, Oct. 29, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its first fiscal quarter ended September 30, 2024. First Quarter Fiscal 2025 Summary*: Revenue of $47.2 million, a decrease of 8.1% from the prior year period. Excluding the negative impact of foreign currency fluctuations, first quarter revenue was down approximately 7.7%;Revenue in the Americas decreased 4.2%, and revenue in Asia/Pacific & Europe decreased 19.7%. Excluding the negative impact of foreign currency fluctuations, first quarter rev
SALT LAKE CITY, Oct. 29, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company's Board of Directors has approved a quarterly cash dividend of $0.04 per share of common stock, which will be paid December 16, 2024 to all stockholders of record at the close of business on December 2, 2024. About LifeVantage Corporation LifeVantage Corporation® (NASDAQ:LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our prod
SALT LAKE CITY, Oct. 29, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leader in health and wellness solutions designed to activate optimal health processes at the cellular level, today announced groundbreaking results from a human clinical trial performed on the new MindBody GLP-1 System™. Results from the trial included a 140% average increase in GLP-1 levels in the body leading to an average weight loss of 9 pounds in 8 weeks and up to 25 pounds in 12 weeks in participants. Ω ‡ Production of GLP-1 (glucagon-like peptide-1) in the body declines due to age, poor diet, stress, or other lifestyle factors. The decline can cause cravings, false hunger, and weight gain. Th
Craig Hallum initiated coverage of Lifevantage with a rating of Buy and set a new price target of $35.00
Lake Street initiated coverage of Lifevantage with a rating of Buy and set a new price target of $26.00
SALT LAKE CITY, Oct. 29, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its first fiscal quarter ended September 30, 2024. First Quarter Fiscal 2025 Summary*: Revenue of $47.2 million, a decrease of 8.1% from the prior year period. Excluding the negative impact of foreign currency fluctuations, first quarter revenue was down approximately 7.7%;Revenue in the Americas decreased 4.2%, and revenue in Asia/Pacific & Europe decreased 19.7%. Excluding the negative impact of foreign currency fluctuations, first quarter rev
SALT LAKE CITY, Oct. 29, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company's Board of Directors has approved a quarterly cash dividend of $0.04 per share of common stock, which will be paid December 16, 2024 to all stockholders of record at the close of business on December 2, 2024. About LifeVantage Corporation LifeVantage Corporation® (NASDAQ:LFVN), the Activation company, is a pioneer in nutrigenomics—the study of how nutrition and naturally occurring compounds can unlock your genes and the health coded within. Our prod
SALT LAKE CITY, Oct. 15, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its first quarter ended September 30, 2024, after the stock market closes on Tuesday, October 29, 2024. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day. Investors interested in participating in the live call can dial (877) 704-4453 from the U.S. or international callers can dial (201) 389-0920. A telephone replay will be available approximately two hours
SALT LAKE CITY, Aug. 28, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company's Board of Directors has approved a quarterly cash dividend of $0.04 per share of common stock, which will be paid September 17, 2024 to all stockholders of record at the close of business on September 9, 2024. About LifeVantage Corporation LifeVantage Corporation (NASDAQ:LFVN), the activation company, is a pioneer in nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. The Company en
SALT LAKE CITY, Aug. 28, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its fourth quarter and full fiscal year ended June 30, 2024. Fourth Quarter Fiscal 2024 Summary*: Revenue of $48.9 million, a decrease of 9.8% from the prior year period. Excluding the negative impact of foreign currency fluctuations, fourth quarter revenue was down approximately 8.0%;Revenue in the Americas decreased 4.1% and revenue in Asia/Pacific & Europe decreased 25.2%. Excluding the negative impact of foreign currency fluctuations, fourth
SALT LAKE CITY, Aug. 14, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its fourth quarter and full fiscal year ended June 30, 2024, after the stock market closes on Wednesday, August 28, 2024. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day. Investors interested in participating in the live call can dial (877) 704-4453 from the U.S. or international callers can dial (201) 389-0920. A telephone replay will be available approx
SALT LAKE CITY, May 02, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company's Board of Directors has approved a quarterly cash dividend of $0.04 per share of common stock, which will be paid June 14, 2024 to all stockholders of record at the close of business on May 31, 2024. This represents an increase in the dividend amount by 14.3% over the previous quarter. About LifeVantage Corporation LifeVantage Corporation (NASDAQ:LFVN), the activation company, is a pioneer in nutrigenomics, the study of how nutrition and naturally o
SALT LAKE CITY, May 02, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today reported financial results for its third fiscal quarter ended March 31, 2024. Third Quarter Fiscal 2024 Summary*: Revenue of $48.2 million, a decrease of 10.2% from the prior year period. Excluding the negative impact of foreign currency fluctuations, third quarter revenue was down approximately 8.7%;Revenue in the Americas decreased 5.9%, and revenue in Asia/Pacific & Europe decreased 22.4%. Excluding the negative impact of foreign currency fluctuations, third quarter revenue
SALT LAKE CITY, April 18, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results for its third quarter ended March 31, 2024, after the stock market closes on Thursday, May 2, 2024. The Company will hold a conference call for investors at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) that same day. Investors interested in participating in the live call can dial (877) 704-4453 from the U.S. or international callers can dial (201) 389-0920. A telephone replay will be available approximately two hours after t
SALT LAKE CITY, March 18, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health at the cellular level, proudly celebrated Consultant success at Momentum Academy 2024 from March 14-16 at the Gaylord Opryland Resort & Convention Center in Nashville, Tennessee. The event was a significant milestone in the Company's commitment to growth, embodying the 'Rise Up' theme and showcasing the U.S. launch of a revamped TrueScience® Activated Skincare Collection as well as the introduction of TrueScience® TrueProtect Daily Mineral Sunstick, a broad-spectrum, mineral-based, sheer sunscreen. LifeVantage Pre
SC 13D/A - Lifevantage Corp (0000849146) (Subject)
SC 13D/A - Lifevantage Corp (0000849146) (Subject)
SC 13D/A - Lifevantage Corp (0000849146) (Subject)
SC 13G/A - Lifevantage Corp (0000849146) (Subject)
SC 13D/A - Lifevantage Corp (0000849146) (Subject)
SC 13D/A - Lifevantage Corp (0000849146) (Subject)
SC 13D/A - Lifevantage Corp (0000849146) (Subject)
SC 13D/A - Lifevantage Corp (0000849146) (Subject)
SC 13D - Lifevantage Corp (0000849146) (Subject)
SC 13G/A - Lifevantage Corp (0000849146) (Subject)
4 - Lifevantage Corp (0000849146) (Issuer)
4 - Lifevantage Corp (0000849146) (Issuer)
4 - Lifevantage Corp (0000849146) (Issuer)
4 - Lifevantage Corp (0000849146) (Issuer)
4 - Lifevantage Corp (0000849146) (Issuer)
4 - Lifevantage Corp (0000849146) (Issuer)
4 - Lifevantage Corp (0000849146) (Issuer)
4 - Lifevantage Corp (0000849146) (Issuer)
4 - Lifevantage Corp (0000849146) (Issuer)
4 - Lifevantage Corp (0000849146) (Issuer)
4 - Lifevantage Corp (0000849146) (Issuer)
4 - Lifevantage Corp (0000849146) (Issuer)
4 - Lifevantage Corp (0000849146) (Issuer)
4 - Lifevantage Corp (0000849146) (Issuer)
4 - Lifevantage Corp (0000849146) (Issuer)
4 - Lifevantage Corp (0000849146) (Issuer)
4 - Lifevantage Corp (0000849146) (Issuer)
4 - Lifevantage Corp (0000849146) (Issuer)
4 - Lifevantage Corp (0000849146) (Issuer)
S-8 - Lifevantage Corp (0000849146) (Filer)
8-K - Lifevantage Corp (0000849146) (Filer)
8-K - Lifevantage Corp (0000849146) (Filer)
8-K - Lifevantage Corp (0000849146) (Filer)
10-Q - Lifevantage Corp (0000849146) (Filer)
DEFA14A - Lifevantage Corp (0000849146) (Filer)
DEF 14A - Lifevantage Corp (0000849146) (Filer)
S-8 - Lifevantage Corp (0000849146) (Filer)
8-K - Lifevantage Corp (0000849146) (Filer)
10-K - Lifevantage Corp (0000849146) (Filer)
SALT LAKE CITY, Jan. 16, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation® (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, is proud to announce the addition of Todd Thompson as Chief Information and Innovation Officer. Todd brings decades of experience driving transformative technology solutions and business growth for prominent global organizations. "We are thrilled to welcome Todd to the LifeVantage team," said Steve Fife, President and CEO of LifeVantage. "Todd's exceptional track record in technology leadership and his forward-thinking approach will be pivotal as we continue along our growth path
SALT LAKE CITY, Aug. 26, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, announced the appointment of Rajendran Anbalagan to the Company's Board of Directors effective today. The appointment comes after the Board conducted a comprehensive search to identify a candidate with transformational digital skills and identified Mr. Anbalagan as an exceptional choice. "We are very excited to welcome Rajendran Anbalagan to the LifeVantage Board," said Ray Greer, Chairman. "Raj brings extensive technology experience along with a deep understanding of how to lever
SALT LAKE CITY, July 22, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, will host Open House calls on July 23 and 24, for anyone wanting to learn more about LifeVantage, its activating products, and the Company's industry-leading compensation plan designed to meet modern sharers by supporting both product sellers and team builders. The Open House call on the 23rd will feature a Q&A with LifeVantage President and CEO, Steve Fife, Chief Sales Officer, Kristen Cunningham, and Regional Vice President of Sales, Jake Hines. The discussion will include the e
SALT LAKE CITY, Feb. 15, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced the appointment of Dayton Judd to the Company's Board of Directors (the "Board"), effective immediately, in an expansion of the Board. The Company has had discussions with Bradley L. Radoff and Sudbury Capital Fund, LP (collectively with certain of their affiliates, the "Radoff-Sudbury Group"), which owns approximately 12.6% of the Company's outstanding stock, since the Company's fiscal year 2024 annual meeting of shareholders held on November 6, 2023. During these dis
SALT LAKE CITY, Nov. 27, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) ("LifeVantage" or the "Company"), a leading health and wellness company with products designed to activate optimal health processes, today announced that the Board of Directors has appointed Raymond Greer as Chairman of the Board. He succeeds Garry Mauro, who will continue to serve as a member of the Board of Directors. "We want to thank Garry for his many contributions while serving as Chairman. He provided critical leadership around our efforts to revamp the management team over the past several years and helped to shape our comprehensive strategic LV360 transformation," said Steve Fife, President an
SALT LAKE CITY, Feb. 17, 2022 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) today announced the appointment of Cindy Latham to the Company's Board of Directors. Latham is a senior-level marketing executive with over 30 years of experience leading global marketing, research and development, and product teams in direct selling organizations. Garry Mauro, Chairman, said of the appointment: "We are delighted to welcome Cindy to the LifeVantage Board. She is a proven leader with outstanding industry experience and a strong track record of driving growth." "It's an honor to join the Board at this time, to help shape new strategies and tactics that leverage the incredible power
SALT LAKE CITY, Oct. 25, 2021 (GLOBE NEWSWIRE) -- LifeVantage Corporation (NASDAQ:LFVN) today announced the appointment of Carl Aure as Chief Financial Officer. Mr. Aure brings more than 24 years of finance and accounting experience including over 15 years in the direct selling industry. He will join the Company on October 25, 2021. "We are pleased to welcome Carl to the LifeVantage team. His deep financial expertise along with an extensive background in direct selling and international operations make him the ideal candidate to lead all aspects of finance, accounting, tax and treasury," said Steve Fife, President and Chief Executive Officer of LifeVantage. "Carl is also a proven leader w
SALT LAKE CITY, Feb. 02, 2021 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN) announced today that its Board of Directors has named Steven Fife as President and Chief Executive Officer. Mr. Fife’s appointment is effective immediately as he has been serving as Interim Chief Executive Officer since September, 2020. He also joins the Board of Directors. “Steve is a highly experienced and accomplished executive with a deep understanding of our business and a clear vision for the future,” said Garry Mauro, the Company’s Chairman of the Board. Mauro continued, “Steve has been instrumental in the growth and success of the Company since joining as CFO in 2017. As we conducted our sear